Aa
Aa
A
A
A
Close
382218 tn?1341181487

MS News: MRI Can Predict Multiple Sclerosis Progression

MRI Can Predict Multiple Sclerosis Progression

www. medicalnewstoday. com/articles/128355. php

6 Nov 2008

"A new study published in Journal of Neuroimaging shows that MRI scans used on multiple sclerosis (MS) patients to determine if the disease has affected gray matter in the brain can identify those at-risk for progression of disability.

MS affects approximately 400,000 people in the United States and as many as 2.5 million worldwide. It is the most common cause of progressive disability in young adults. While the cause of the disease remains unknown, it is characterized by damage to the covering over the nerve fibers in the brain and spinal cord, or to the nerve fiber itself.

In an attempt to understand the causes of disease progression, researchers at the Partners MS Center, led by Dr. Rohit Bakshi and his team, have developed new ways to detect gray matter damage.

Dr. Bakshi, Director of the Laboratory for Neuroimaging Research and an Associate Professor of Neurology and Radiology at the Brigham and Women's Hospital and Harvard Medical School, led a four year follow-up study, which found that patients with unnatural darkness of gray matter structures as seen on MRI pictures carried a higher risk for progression of physical disability. This abnormal darkness is referred to as T2 hypointensity, and is suggestive of excessive iron deposits. In addition, the researchers found that the new marker of gray matter damage showed closer correlations with patients' clinical status than other established MRI markers of disease severity, including lesions, also known as "plaques," and shrinkage of the brain, also know as "atrophy."

"MRI scans obtained from patients with MS are being used to develop measures and techniques that can accurately measure the visible and hidden damage to the brain, especially in gray matter areas and can more accurately predict the course of the disease," says Bakshi.

As a result of the findings, MRI-based measurement of gray matter damage may be used as a surrogate marker of disease progression. Physicians may therefore be able to more accurately identify patients at risk for developing this progressive disease.

MS has been traditionally viewed as a disease affecting the white matter of the brain, where messages are transferred between the brains gray matter sections, which control the processing of information. While prior research has shown that the brain's gray matter is also affected, studies detailing its effects have been limited. In addition, current therapies for MS are incomplete, raising the need to better understand disease mechanisms and the biomarkers of disease progression. If excessive iron in gray matter contributes to damage, this would open a new avenue for developing better therapies."
8 Responses
Sort by: Helpful Oldest Newest
147426 tn?1317265632
okay, i'll rein in my ego.....but it sure feels good.  Remember, it's Snoopy with cement boots on  :((

I just read another study by Bakshi on the same topic.  This appears to be an extension of that study, published in 2006.  I agree it does not appear that they used Gad.  On the earlier study they used 1.5T MRIs.  It's just that they focused on the gray matter.  I'm still not sure, but it sounds like these things should be visible to our radiologists.  They may not be skilled in looking for them or seeing them.

Apparently it has been known for a decade that the iron metabolism in the brain is altered in MS.  So those areas of increased iron deposits would be lesions - in that they are areas of abnormality.

Still learning

:))  Quizzle Sticks
Helpful - 0
572651 tn?1530999357
Q- don't hurt yourself with all that happy Snoopy dancing you've been entitled to do this week!!  Lu
Helpful - 0
338416 tn?1420045702
This is great!  This goes back to an article I read last year about T2 hypointensities and activity in the gray matter.  They noticed that parts of the gray matter in an MS patient would react to an MRI scan, even though there were no lesions in the area.  

My take on it is that gadolinium would not help to enhance the hypointensities.  There are no lesions, just excessive deposition of iron.
Helpful - 0
147426 tn?1317265632
The black holes are typically seen in the white matter on the T1 imaging sequence.  They are areas of "drop-out" from the white matter.

I don't know about the use of Gad to see the gray matter lesions.  I will need to look at the actual study to see what techniques and what power of MRI they used for the study.

So we are seeing that there is much more to our disease than the T2 Hyperintensities.  So much for Lesion Counting Neuros!  (pat on back)  I've been telling you all along that there was, much more going on!

Quix
Helpful - 0
Avatar universal
bump for Quix
Helpful - 0
Avatar universal
I had formed the idea that T2 hypointensity is the same thing as the "black holes" we have heard about. I guess this is wrong, so I'd appreciate clarification as to what the black holes really are.

Thanks.

ess
Helpful - 0
382218 tn?1341181487
Do you know whether gadolinium would have to be administered in order for this abnormal darkness, ie T2 hypointensity, to show up on the MRI?
Helpful - 0
147426 tn?1317265632
Yep!  Thanks DeeBee!
Helpful - 0
Have an Answer?

You are reading content posted in the Multiple Sclerosis Community

Top Neurology Answerers
987762 tn?1671273328
Australia
5265383 tn?1669040108
ON
1756321 tn?1547095325
Queensland, Australia
1780921 tn?1499301793
Queen Creek, AZ
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease